Pharmaceuticals

Genetic_Screening_Testing_for_Preventive_Health_Market.JPG

Genetic Screening Testing for Preventive Health Market Size, Share & Trends Analysis Report By test type (Carrier Screening Tests (Expanded Carrier Screening, Targeted Carrier Screening), Non-Invasive Prenatal Tests, Preimplantation Genetic Testing, And Newborn Screening), Technology (NGS, Microarray, PCR, FISH), Application (Oncology, Cardiovascular Diseases, Reproductive Health, Neurodegenerative Health, Rare Diseases), And End-User (Hospitals And Diagnostic Laboratories, Dtc Companies, Genetic Counselling Services), By Region, And By Segment Forecasts, 2025-2034.

Genetic Screening Testing for Preventive Health Market is predicted to grow at a 11.8% CAGR during the forecast period for 2025-2034. Analyzing a person's genetic composition to forecast their risk of contracting specific diseases or ailments in t...

View Sample PDF

Dopamine_Agonist_Market.JPG

Dopamine Agonist Market Size, Share & Trends Analysis Report By Drug (Ergot Alkaloids, Non-Ergot Dopamine Agonists), By Application (Parkinson's Disease, Restless Legs Syndrome (RLS), Hyperprolactinemia, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Pharmacies), By Region, And By Segment Forecasts, 2025-2034.

Dopamine Agonist Market Size is valued at USD 1.4 billion in 2024 and is predicted to reach USD 2.9 billion by the year 2034 at a 7.4% CAGR during the forecast period for 2025-2034. Dopamine agonists are a class of drugs that imitate the effects o...

View Sample PDF

main_IMG.JPG

Virtual Biopsy Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders), Type Of Cancer, Type Of Imaging Technology, And End-user, By Region, And By Segment Forecasts, 2025-2034

Global Virtual Biopsy Market is valued at USD 0.8 Billion in 2024 and is predicted to reach USD 2.1 Billion by the year 2034 at a 12.3% CAGR during the forecast period for 2025-2034.  A virtual biopsy is a non-invasive diagnostic method that ...

View Sample PDF

Main_Img.JPG

Inhalable Biologics Market Size, Share & Trends Analysis Report By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region, And By Segment Forecasts, 2025-2034.

Global Inhalable Biologics Market is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 17.2 Billion  by the year 2034 at an 19.4% CAGR during the forecast period for 2025-2034. Inhalable biologics are biologic drugs that are bre...

View Sample PDF

Mian_IMg.JPG

Nasal Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines), By Application (Influenza, COVID-19), By Region, And By Segment Forecasts, 2025-2034

Global Nasal Vaccines Market is valued at USD 466.2 Million in 2024 and is predicted to reach USD 935.2 Million by the year 2034 at 8.6% CAGR during the forecast period for 2025-2034. Nasal vaccinations are a non-invasive substitute for conve...

View Sample PDF

Main_IMG2.JPG

Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Others), By Distribution Channel (Retail Stores, Online Stores, Others), By Region, And By Segment Forecasts, 2025-2034

Global Emergency Contraceptive Pills Market is valued at USD 602.3 Million in 2024 and is predicted to reach USD 1,015.3 Million by the year 2034 at a 6.3% CAGR during the forecast period for 2025-2034. Emergency contraceptive pills (ECP...

View Sample PDF

Main_IMg.JPG

Hedgehog Pathway Inhibitors Market Size, Share & Trends Analysis Report By Generic Drug (Glasdegib, Sonidegib, Vismodegib), By Dosage (Capsule and Injection), By End User (Homecare, Hospitals, Specialty Clinics), By Region, And By Segment Forecasts, 2025-2034

Global Hedgehog Pathway Inhibitors Market is valued at USD 509.2 Million in 2024 and is predicted to reach USD 1,115.0 Million by the year 2034 at a 9.8% CAGR during the forecast period for 2025-2034. Hedgehog pathway inhibitors are part...

View Sample PDF

Main_Img1.JPG

Blood-Based Biomarker for Sports Medicine Market Size, Share & Trends Analysis Report By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6), By Region, And By Segment Forecasts, 2025-2034

Global Blood-Based Biomarker for Sports Medicine Market is valued at USD 757.8 Million in 2024 and is predicted to reach USD 1,423.9 Million by the year 2034 at a 7.8% CAGR during the forecast period for 2025-2034. Sports medicine blood-based biom...

View Sample PDF

Main.JPG

Organic Pharmaceutical Excipients Market Size, Share & Trends Analysis Distribution- By Type (Oleochemicals, Carbohydrates, Petrochemicals, Protein, Other), By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions), By Region and Segment Forecasts, 2025-2034

Global Organic Pharmaceutical Excipients Market Size is valued at USD 10.2 Billion in 2024 and is predicted to reach USD  27.6 Billion by the year 2034 at an 10.7% CAGR during the forecast period for 2025-2034. Organic pharmaceutical excipien...

View Sample PDF

main_img.JPG

Insomnia Pharmacological Treatment Market Size, Share & Trends Analysis Report, By Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements, Prescription Drugs), By Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), By Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), By Region, Forecasts, 2025-2034

 Global Insomnia Pharmacological Treatment Market Size was valued at USD 3.9 Billion in 2024 and is predicted to reach USD 7.3 Billion by 2034 at a 6.6% CAGR during the forecast period for 2025-2034. Insomnia pharmacological treatment disorde...

View Sample PDF

Categories